Statistics
Total Visits
| Views | |
|---|---|
| A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG) | 116 |
Total Visits Per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG) | 0 | 0 | 17 | 2 | 1 | 1 | 1 |
Top country views
| Views | |
|---|---|
| Poland | 52 |
| United States | 52 |
| France | 3 |
| Ireland | 2 |
| Germany | 1 |
| EU | 1 |
| Greece | 1 |
| Russia | 1 |
| Sweden | 1 |
| Togo | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 52 |
| Louisville | 11 |
| Boardman | 10 |
| Des Moines | 9 |
| San Ramon | 8 |
| Ann Arbor | 5 |
| Dublin | 2 |
| Fairfield | 2 |
| Ashburn | 1 |
| Athens | 1 |